Gönderi
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
102 Beğeni5 Beğenmeme10 Yeniden paylaşım1 Yorumlar
?
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
Henüz yorum yok. İlk yorumu sen yap!
Yorumlar
Henüz yorum yok. İlk yorumu sen yap!